The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands-Reference-Cited by-同舟云学术

The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands

Published:2015-02 Issue:2 Volume:39 Page:177-182
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Dinmohamed Avinash G.,van Norden Yvette,Visser Otto,Posthuma Eduardus F.M.,Huijgens Peter C.,Sonneveld Pieter,van de Loosdrecht Arjan A.,Jongen-Lavrencic Mojca

Funder

The Netherlands Organization for Health Research and Development

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference33 articles.

1. Myelodysplastic syndromes;Nimer;Blood,2008

2. An evolutionary perspective on chronic myelomonocytic leukemia;Itzykson;Leukemia,2013

3. Myelodysplastic syndromes: incidence and survival in the United States;Ma;Cancer,2007

4. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001–2004, using data from the NAACCR and SEER programs;Rollison;Blood,2008

5. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project;Sant;Blood,2010

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Myelomonocytic Leukemia and Atypical Chronic Myeloid Leukemia: A National Analysis;Clinical Lymphoma Myeloma and Leukemia;2024-07

2. Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11);International Journal of Hematology;2023-12-13

3. Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11);International Journal of Hematology;2023-11-28

4. Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine—A prospective cohort study by the AGMT;American Journal of Hematology;2023-08-07

5. Prevalence and treatment of anemia and secondary iron overload in patients with a myelodysplastic syndrome: Real-world data from a multicenter cohort study;Transfusion Clinique et Biologique;2023-08